Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Synthesis and bioevaluation of some new isoniazid derivatives.

Matei L, Bleotu C, Baciu I, Draghici C, Ionita P, Paun A, Chifiriuc MC, Sbarcea A, Zarafu I.

Bioorg Med Chem. 2013 Sep 1;21(17):5355-61. doi: 10.1016/j.bmc.2013.06.013. Epub 2013 Jun 15.

PMID:
23823011
2.

Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.

Rodrigues MO, Cantos JB, D'Oca CR, Soares KL, Coelho TS, Piovesan LA, Russowsky D, da Silva PA, D'Oca MG.

Bioorg Med Chem. 2013 Nov 15;21(22):6910-4. doi: 10.1016/j.bmc.2013.09.034. Epub 2013 Sep 20.

PMID:
24103427
3.

Synthesis and biological activities of some new isonicotinic acid 2-(2-hydroxy-8-substituted-tricyclo[7.3.1.0(2.7)]tridec-13-ylidene)-hydrazides.

Matei L, Bleotu C, Baciu I, Diaconu CC, Hanganu A, Banu O, Ionita P, Paun A, Tatibouët A, Zarafu I.

Bioorg Med Chem. 2015 Feb 1;23(3):401-10. doi: 10.1016/j.bmc.2014.12.038. Epub 2014 Dec 26.

PMID:
25557899
4.

Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.

Sriram D, Yogeeswari P, Madhu K.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4502-5.

PMID:
16115763
5.

Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.

Hearn MJ, Cynamon MH.

J Antimicrob Chemother. 2004 Feb;53(2):185-91. Epub 2003 Dec 19.

PMID:
14688045
6.
7.
8.
9.

Researches concerning the synthesis and antituberculosis action of some new sulphacetamide derivatives.

Ungureanu M, Diculencu D, Stirbu CA.

Rev Med Chir Soc Med Nat Iasi. 2006 Apr-Jun;110(2):456-9.

PMID:
17802961
10.

Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.

Kumar A, Patel G, Menon SK.

Chem Biol Drug Des. 2009 May;73(5):553-7. doi: 10.1111/j.1747-0285.2009.00804.x.

PMID:
19366360
11.

N-benzylsalicylthioamides: highly active potential antituberculotics.

Dolezal R, Waisser K, Petrlíková E, Kunes J, Kubicová L, Machácek M, Kaustová J, Dahse HM.

Arch Pharm (Weinheim). 2009 Feb;342(2):113-9. doi: 10.1002/ardp.200800032.

PMID:
19137534
12.

Synthesis and antimycobacterial evaluation of new trans-cinnamic acid hydrazide derivatives.

Carvalho SA, da Silva EF, de Souza MV, Lourenço MC, Vicente FR.

Bioorg Med Chem Lett. 2008 Jan 15;18(2):538-41. Epub 2007 Nov 28.

PMID:
18068364
13.
14.

Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis.

Swamy BN, Suma TK, Rao GV, Reddy GC.

Eur J Med Chem. 2007 Mar;42(3):420-4. Epub 2006 Nov 15.

PMID:
17112641
15.
17.

[Synthesis and antituberculosis activity of the derivatives of glycoside steviolbioside from the plant Stevia rebaudiana and diterpenoid isosteviol containing hydrazone, hydrazide and pyridinoyl moieties].

Kataev VE, Strobykina IIu, Andreeva OV, Garifullin BF, Sharipova RR, Mironov VF, Chestnova RV.

Bioorg Khim. 2011 Jul-Aug;37(4):542-51. Russian.

PMID:
22096997
18.

Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.

Sinha N, Jain S, Tilekar A, Upadhayaya RS, Kishore N, Jana GH, Arora SK.

Bioorg Med Chem Lett. 2005 Mar 15;15(6):1573-6.

PMID:
15745799
19.

Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.

De P, Koumba Yoya G, Constant P, Bedos-Belval F, Duran H, Saffon N, Daffé M, Baltas M.

J Med Chem. 2011 Mar 10;54(5):1449-61. doi: 10.1021/jm101510d. Epub 2011 Feb 10.

PMID:
21309577
20.

Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9.

Bottari B, Maccari R, Monforte F, Ottanà R, Rotondo E, Vigorita MG.

Bioorg Med Chem Lett. 2000 Apr 3;10(7):657-60.

PMID:
10762047

Supplemental Content

Support Center